Testolone – RAD-140 10mg
Testolone is presented in the ORYVION catalog as a tablet formulation containing 10mg of RAD-140 per tablet, supplied in containers of 50 tablets. RAD-140 is an investigational, orally active, nonsteroidal selective androgen receptor modulator (SARM).
Its mechanism of action involves binding to androgen receptors and modifying androgen-dependent cellular signaling. Early clinical research has investigated its activity in postmenopausal women with certain advanced breast cancers. These studies do not establish its safety or effectiveness for increasing muscle mass, improving strength, or enhancing athletic performance in healthy individuals.
Product Specifications:
Commercial name: Testolone
Listed compound: RAD-140
Declared strength: 10mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
Elevated liver enzymes and bilirubin were reported in an early clinical trial of RAD-140, and published case reports describe serious liver injury associated with its use. SARMs also carry concerns regarding hormonal, reproductive, and cardiovascular effects.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.